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Abstract
In observational clinic registries, time to treatment is often of interest, but treat-
ment can be given at any time during follow-up and there is no structure or interven-
tion to ensure regular clinic visits for data collection. To address these challenges, we
introduce the time-dependent propensity process as a generalization of the propensity
score. We show that the propensity process balances the entire time-varying covari-
ate history which cannot be achieved by existing propensity score methods and that
treatment assignment is strongly ignorable conditional on the propensity process.
We develop methods for estimating the propensity process using observed data and
for matching based on the propensity process. We illustrate the propensity process
method using the Emory Amyotrophic Lateral Sclerosis (ALS) Registry data.
Keywords: Balancing Score; Generalized Propensity Score; Propensity Process; Propensity
Score; Observational Registry; Time-Varying Covariates
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1 Introduction
Amyotrophic lateral sclerosis (ALS) is a rare progressive neurological disorder resulting
in the degeneration of both upper motor neurons of the cerebral cortex and lower mo-
tor neurons of the spinal cord and peripheral nervous system, with a very poor progno-
sis. Currently, there is no cure for ALS and clinical care is generally limited to treating
secondary infections and palliative care, such as surgically inserting a percutaneous en-
dogastrostomy (PEG) tube to provide enteral nutrition for individuals having difficulty
swallowing (Procaccini and Nemergut, 2008). Our objective is to assess the effect of insert-
ing a PEG feeding tube on preventing weight loss. PEG insertion is an individual decision
and one that must be made while the individual is strong enough to proceed with surgery.
Hence, a randomized controlled trial to study the effect of PEG would be implausible. We
develop new methods to evaluate PEG using data from the Emory ALS Clinic registry.
Let T denote the continuously-defined time of PEG insertion for a randomly selected
patient from the population. The observed outcome Y is collected at or just after a fixed
point at time L, which consequently restricts the time of PEG insertion. If subjects were
randomly assigned to receive PEG prior to L and randomly assigned to treatment times,
then both treatment effect and dose-response curve could be estimated using standard
methods. However, treatment assignment depends on patient characteristics and confounds
the effect of treatment on outcome. To remove confounding associated with covariate im-
balance among treatment levels, we rely on the general concept of the propensity score
(Rosenbaum and Rubin, 1983; Rubin and Thomas, 1996).
When treatment assignment is binary, the propensity score (Rosenbaum and Rubin,
1983) is defined as probability of receiving a treatment given a set of observed vari-
ables. Generalizations of the propensity score as a balancing score have been investi-
gated in various settings (Hirano and Imbens, 2004; Imai and Van Dyk, 2004; Hansen,
2008; Allen and Satten, 2011; Hu et al., 2014). For continuously-defined treatment levels,
Hirano and Imbens (2004) proposed a direct translation of the propensity score by replacing
the conditional probability mass function with the conditional density function of treat-
ment assignment given covariates, known as a generalized propensity score (GPS); while
2
this approach leads to as many propensity scores as there are levels of the treatment it uses
only one single score at a time. Although Imai and Van Dyk (2004) similarly found that
the conditional density function of treatment assignment given covariates could serve as a
propensity score, they noted potential limitations of this approach and suggested instead
using the linear predictor in regression models or other summary statistic that are of finite
dimension. When treatment assignment occurs over time as in the case where an individual
chooses to receive PEG insertion or not, we must allow for the possibility of time-dependent
confounding. To this end, let Xt denote a set of p-dimensional time-dependent covariates
at time t and Xt = {Xs, 0 ≤ s ≤ t} denote the history of covariates up to time t. Then,
the probability of treatment assignment at time t given the covariate history up to time t
is
f(t | Xt) = lim
ǫ→0
ǫ−1P (t ≤ T < t + ǫ | Xt) , (1)
where f(t | Xt) = h(t | Xt) exp
{
−
∫ t
0
h(s | Xs) ds
}
and the hazard function is
h(t | Xt) = lim
ǫ→0
ǫ−1P (t ≤ T < t+ ǫ | T ≥ t, Xt) . (2)
Because h(t | Xt) uniquely parameterises f(t | X⊔), either model (1) or model (2) may
be regarded as a legitimate treatment assignment model for continuous treatment with
time-independent or time-dependent confounding (Li et al., 2001; Lu, 2005).
Of note, f(t | X⊔) is a function of the entire covariate history Xt, whereas the haz-
ard function h(t | Xt) is a function of Xt only. This subtle, yet important difference can
lead to difficulties when extending methods proposed by Imai and Van Dyk (2004) and
Hirano and Imbens (2004) to time-dependent confounding via standard hazard modeling.
In addition, both Li et al. (2001) and Lu (2005) used the hazard function h(t | Xt) as a
GPS for matching which allows for balancing Xt at the time of treatment in a matched set.
However, they did not establish the strong ignorability of treatment assignment given their
time-dependent GPS; this property does not hold if Y is associated with Xt rather than
just Xt, in which case their proposed procedures may not lead to valid causal inference.
Additionally, their proposed methods are only applicable to studies with data routinely
collected at regular intervals, which is often not true in clinical registries.
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We propose the propensity process to correct for confounding in observational studies by
balancing the covariate history Xt. After the propensity process is estimated, bias-corrected
data analyses can be achieved through matching or stratification (Rosenbaum and Rubin,
1983). Establishing formally the theoretical properties of the propensity process for time-
independent confounding requires different arguments than those presented in Imai and Van Dyk
(2004).
2 Methods
2.1 Notation and Assumptions
Our framework is constructed through potential outcomes (Rubin, 2005). For t ∈ [0, L), we
define Ut = T ∧ t as the treatment time restricted to time t and U = T ∧L as the treatment
time restricted to time L, where a∧ b denotes the minimum of a and b. Let Tt = {[0, t), t+}
define the set of potential treatment times restricted to t, t ∈ [0, L), where t+ means that
a patient did not receive PEG treatment before t. Let Y ∗t be the potential outcome if a
subject received PEG treatment at time t, t ∈ [0, L), and Y ∗t+ the potential outcome if a
subject did not receive PEG treatment in the interval [0, t). It follows that Y ∗L+ denotes the
potential outcome if a subject did not receive PEG treatment in the interval [0, L). We also
define the treatment-free potential covariate process X ∗t , t ≤ L. Then, the set of potential
outcomes and treatment-free potential covariate process for a randomly selected subject
from the population is {Y ∗s ,X
∗
s , s ∈ Tt} when treatment time is restricted at t, t ∈ [0, L).
In contrast, the observed data are (Y, U,XU), where the observed outcome Y = Y
∗
U , and
the observed covariate history XU = X
∗
U .
Given θt = h(t | X
∗
t ), we define the propensity process as the sample path of the hazard
function from baseline to time t, i.e.,
Θt = {θs = h(s | X
∗
s ), 0 ≤ s ≤ t} , (3)
noting that Θt is dependent on X
∗
t . As X
∗
t is observable only up to U , Θt is estimable only
up to U . While this concept seems similar to the propensity function (Imai and Van Dyk,
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2004), the distinguishing factor of the propensity process is that Θt depends on t and is of
infinite dimension and ΘL cannot be fully estimated for subjects receiving PEG before L,
whereas the propensity function in Imai and Van Dyk (2004) only allows for incorporation
of time-independent covariates and can be estimated for all subjects.
In our framework, we make two assumptions.
Assumption 1 (Stable unit treatment value assumption) The distributions of po-
tential outcomes for different subjects are independent of one another.
Assumption 2 (Strong Ignorability) For every t ∈ [0, L), pr(Ut ∈ A | Y
∗
s ,X
∗
t ) =
pr(Ut ∈ A | X
∗
t ) and pr (Ut ∈ A | X
∗
t ) > 0 for all s ∈ Tt, X
∗
t , and A ⊆ Tt.
Assumption 1 is a common assumption in causal inference. However, our Assumption 2 is
defined for each time point t and differs from the standard strong ignorability of treatment
assignment assumption used in earlier work for balancing scores. One implication of As-
sumption 2 is that, conditional on the treatment-free history X ∗t , receiving treatment at
t or not is independent of the set of potential outcomes, allowing us to model treatment
assignment without conditioning on potential outcomes.
2.2 Main results
We establish the large-sample results of the propensity process assuming that the true
propensity process is known along the lines of Rosenbaum and Rubin (1983) and Imai and Van Dyk
(2004).
Proposition 1 U is conditionally independent of treatment-free covariate history X ∗L given
ΘL, where X
∗
L and ΘL are the entire treatment-free covariate history and propensity process,
respectively.
Proposition 1 establishes ΘL as a balancing functional that balances the entire covariate
history. Proposition 1 requires that ΘL is known or can be estimated in the entire domain
[0, L). In practice, however, we can only observe the covariate process X ∗U and hence estimate
ΘU . Proposition 2 establishes the balancing property for every given time point t in [0, L).
5
Proposition 2 For every t ∈ [0, L), Ut is conditionally independent of treatment-free co-
variate history X ∗t given Θt, where X
∗
t and Θt are the treatment-free covariate history and
propensity process through time t, respectively.
When t = U in Proposition 2, we have that U is independent of treatment-free covariate
history X ∗U given ΘU , where X
∗
U = XU is observable and hence ΘU is estimable.
Theorem 1 For every t ∈ [0, L), pr (Ut ∈ A | Y
∗
s ,Θt) = pr(Ut ∈ A | Θt) for all s ∈ Tt, Θt,
and A ⊆ Tt.
When t = U in Theorem 1, we have that U is independent of potential outcomes given ΘU ,
where ΘU is estimable. Several remarks are in order. First, in § 3.1 we suggest modeling
the hazard function in (2) through the proportional hazards model (4); one could also
use other model formulations for (2) and the results in Propositions 1–2 and Theorem 1
would still apply. Second, Proposition 2 and Theorem 1 provide justifications for matching
a subject treated at t with an eligible control subject untreated at t based on the propensity
process up to t. It follows that each matched pair would have the same distribution for the
covariate process up to t and their potential outcomes are independent of their treatment
assignments, allowing for valid causal inference. Third, our Proposition 2 is similar in spirit
to Proposition 1 in Lu (2005) but is more general in the sense that the propensity process
balances the entire covariate history up to t not just the covariates measured at t. In
addition, Lu (2005) did not establish the strong ignorability of treatment assignment given
propensity scores similar to our Theorem 1. Proofs for Propositions 1–2 and Theorem 1 are
given in the Appendix.
3 Implementation and Practical Considerations
3.1 Interpolated Propensity Processes
In practice, the propensity process ΘU must be estimated from the observed data. The
challenge for estimating the propensity process is that we may not observe the complete
treatment-free covariate process X ∗U on [0, U ]; rather, we only get to observe the covariate
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process at a coarse set of discrete time points as is the case in the motivating ALS study.
Here, we propose to borrow strength across subjects in the study sample by modeling each
time-dependent covariate as a random curve over time via nonlinear mixed effects models.
This allows a predictive curve to be estimated for the entire treatment-free covariate process
for each subject.
First, suppose we parameterize the hazard function in (2) through Cox’s proportional
hazards model and define the propensity process through the linear predictor,
h(t | Xt; β) = h0(t) exp(β
TXt), Θt =
{
θs = β
TX∗s , 0 ≤ s ≤ t
}
, (4)
where h0(t) is the unspecified baseline hazard function. Next, write the observed treatment-
free covariate history for the i-th subject and k-th covariate as Xik = (Xi1k, . . . , Ximik), with
time-dependent covariate Xijk measured at time tij. We note that the observation times
(tij, j = 1, . . . , mi) may be different for each subject but are assumed to be the same for
all covariates within a subject. Then, for each time-dependent covariate, we fit the model,
Xijk = b
T
k (tij)γk + b
T
k (tij)αik + ǫijk, (i = 1, . . . , n; j = 1, . . . , mi; k = 1, . . . , p), (5)
where ǫijk are independent, mean-zero random errors. To provide greater flexibility in mod-
eling the covariate process over time, we use spline-type models (Ruppert et al., 2003) in
(5) where b(·) denotes a set of basis functions and γk and αik are regression coefficients
corresponding to the basis functions for the fixed and random effects, respectively. The
interpolated treatment-free X̂t can be obtained from model (5) by replacing regression
coefficients γk and αik with their estimates γ̂k and α̂ik, respectively. Then the estimated
propensity process Θ̂U can be obtained from (4) by plugging in the interpolated X̂U and
β̂, where β̂ is the estimated regression coefficient vector in the Cox proportional hazards
model.
3.2 Matching
The use of matched analyses based on propensity scores for testing causal null hypothe-
ses has been advocated by several other authors; for example, see Rosenbaum and Rubin
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(1983), Li et al. (2001) and Lu (2005) and references therein. Matching can be performed
by minimizing the integrated squared error between the estimated propensity process Θ̂t
of a subject who received PEG treatment at time t and that of each eligible control with
U > t. To accomplish this task, we implement a sequential matching algorithm. We start
by ordering chronologically subjects according to their time of PEG treatment or censoring,
namely U . Set the matched pair counter to m = 1 and select the subject with the smallest
time to PEG treatment, say subject i1. Define the integrated squared difference in interpo-
lated propensity processes between i1 and l as Q(i1, l) = I(Ti1 ≤ L)
∫ Ti1
0
(θ̂i1,t − θ̂l,t)
2 dt, for
all subjects l in the set of n−1 eligible controls C1 = {l | l = 1, . . . , n, l 6= i}. The matched
control for i1 is the nearest neighbor in interpolated propensity processes among eligible
controls, i.e., argminl∈C1Q(i1, l). Increment the matched pair counter by one to m = 2 and
select the subject with the smallest time to PEG treatment, say i2, excluding the two
subjects in the first matched pair. Therefore, the set of eligible controls, say C2, contains
n − 3 subjects: all n subjects less the two subjects in the first matched pair and i2. The
matched control for i2 is the nearest neighbor in interpolated propensity processes among
the set of eligible controls, argminl∈C2Q(i2, l). Increment the matched pair counter by one
and continue until all treated individuals are matched or until there are no suitable controls
available for matching.
4 Analysis of the ALS Registry Data
Using a data set from the Emory ALS Registry, we assess the association of PEG treatment
with the change in body mass index (BMI) from baseline to 18 months, i.e., L = 18 months.
The data set includes 240 patients who survived past L and had at least one clinic visit
between baseline and L. The patients who received PEG did so after their first clinic visit.
The timing of recommending PEG by the physician involved many factors and the final
decision to have PEG was made by each patient. We model treatment assignment through
the proportional hazards model (4) including the following covariates. The baseline risk
factors are age at diagnosis, sex, site of onset of disease, negative inspiratory force, and
time from diagnosis to the first clinic visit. Two time-varying covariates are forced vital
8
capacity and body mass index, which may not be measured at every clinic visit for every
patient. Each time-varying covariate is modeled over time using the mixed model (5), where
polynomial spline basis functions are used. The estimated curves are used to interpolate
the covariate values needed for estimating the propensity process based on (4).
We compare three alternative approaches to the proposed propensity process. First, a
na¨ıve analysis compares all treated individuals to those who are untreated prior to L. The
second approach is the propensity function (Imai and Van Dyk, 2004) that uses baseline
risk factors X0 only in the treatment assignment model (4), where θ0 = β
TX0 defines the
propensity function. The third approach is the interpolated generalized propensity score,
which uses the interpolated treatment-free X̂t defined in § 3.1 to obtain the GPS for each
subject in the spirit of Lu (2005), noting that Xt may not be observed at time U for a
subject and its eligible controls as defined in § 3.2. The same sequential matching algorithm
in § 3.2 is used for all propensity score methods. Our matching algorithm resulted inM = 74
pairs for the analysis using the propensity function and M = 76 pairs for both analyses
using the generalized propensity score and propensity process.
Following Li et al. (2001) and Lu (2005), we assess balance of covariates by examining
Type I errors from a log-rank test of the effect of the covariate on time to treatment, one
covariate at a time. In the matched analyses, this model is stratified by the M matched
pairs. As shown in Table 1, prior to matching, balance is not achieved. While other methods
improve covariate balance, they do not balance all covariates. However, matching using the
propensity process results in balance across all covariates. This indicates that the propen-
sity process outperforms the baseline propensity function or interpolated GPS in terms of
balancing covariates and there may be residual confounding after matching by the other
propensity score methods.
After matching, we test the causal null hypothesis that the mean potential outcome is
the same whether a patient received PEG treatment at time t versus PEG treatment at
some time after t or untreated by L, which can be written as H0 : E(Y
∗
t ) = E(Y
∗
s ) for all
t < s ≤ L. We test this hypothesis by a Wilcoxon signed rank test on matched pairs for
all the matched analyses. The Wilcoxon rank sum test is used for hypothesis testing in the
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Table 1: Covariate balance before and after matching
Prior to Propensity Generalized Propensity
Covariate Matching Function Propensity Score Process
Body mass index 0.277 0.245 0.986 0.991
Forced vital capacity 0.764 0.539 0.201 0.317
Negative inspiratory force 0.151 0.022 0.016 0.704
Age 0.162 0.718 0.378 0.195
Sex 0.577 0.695 0.002 0.706
Site 0.001 0.003 1.000 0.341
Time from diagnosis 0.676 0.633 0.033 0.854
na¨ıve analysis. Table 2 presents the median difference in BMI change at 18 months and
p-value of the Wilcoxon test for each approach. The propensity process matched analysis
suggests a protective effect of PEG on BMI, whereas the other three methods all show
effects that are attenuated towards 0 and are not statistically significant.
Table 2: Results in the data analysis
Median Difference P-value
Na¨ıve 0.035 0.673
Propensity Function 0.030 0.466
Generalized Propensity Score 0.360 0.453
Propensity Process 0.830 0.022
5 Discussion
Compared to the existing propensity score methods, the propensity process offers the ad-
vantage of balancing time-varying covariate history from baseline to time of treatment. A
key component of this approach is the interpolation of covariate curves. We propose to use
nonlinear mixed models to provide flexibility for modeling covariate history, though there
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must be enough individual longitudinal data collected to estimate these curves, which is
a potential limitation in settings with sparsely collected longitudinal data. However, data
interpolation may not be needed in settings such as critical care in intensive care units
where time series data including heart rate and blood pressure are continuously recorded
(Lehman et al., 2013).
In our data analysis, we use a straightforward approach for hypothesis testing after
matching. Future extensions may include conditional likelihood methods for estimating
treatment effects based on matched pairs/sets and methods for stratification and covariate
adjustment using the propensity process. Additionally, our analysis excludes individuals
who died prior to L in order to avoid complications due to censoring by death (Rubin et al.,
2006; Zhang and Rubin, 2003), which could be addressed in future extensions such that no
such exclusion is necessary.
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Appendix: Proofs of Propositions 1, 2, and Theorem 1
Proof of Propositions 1 and 2: We prove Propositions 1 and 2 based on the treatment
assignment model defined in (1) and (2). Given θt = h(t | X
∗
t ),
f(t | X ∗t ,Θt) = f(t | X
∗
t )
= h(t | X∗t ) exp
{
−
∫ t
0
h(s | X∗s ) ds
}
= θt exp
{
−
∫ t
0
θs ds
}
(6)
= f(t | Θt), for all t ∈ [0, L),
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where the first equality is due to the fact that Θt is redundant given X
∗
t . It follows from
integrating both sides in [0, L] that pr(T ≥ L | X ∗L,ΘL) = pr(T ≥ L | ΘL). The re-
sult in Proposition 1 follows immediately, i.e., U is conditionally independent of X ∗L given
ΘL. Along similar lines, we can prove the result in Proposition 2, i.e., Ut is conditionally
independent of X ∗t given Θt for all t ∈ [0, L).
Proof of Theorem 1: For every t ∈ [0, L), all s ∈ Tt, Θt, and A ⊆ Tt,
pr (Ut ∈ A | Y
∗
s ,Θt) = E {pr (Ut ∈ A | Y
∗
s ,X
∗
t ) | Y
∗
s ,Θt} (7)
= E {pr (Ut ∈ A | X
∗
t ) | Y
∗
s ,Θt} (8)
= E {pr (Ut ∈ A | X
∗
t ,Θt) | Y
∗
s ,Θt} (9)
= E {pr (Ut ∈ A | Θt) | Y
∗
s ,Θt} (10)
= pr (Ut ∈ A | Θt) . (11)
Let σ(Y ∗s ,Θt) and σ(Y
∗
s ,Xt) denote the σ-field generated by (Y
∗
s ,Θt) and (Y
∗
s ,Xt), respec-
tively. By the definition of Θt in (3), we have σ(Y
∗
s ,Θt) ⊆ σ(Y
∗
s ,Xt) and then (7) follows
immediately (cf. Billingsley, 2008, Theorem 34.4). (8) is due to Assumption 2 while (9)
follows from the fact that Θt is redundant given X
∗
t . The fourth expression (10) is due to
Proposition 2 while (11) follows from (6), i.e., pr (Ut ∈ A | Θt) is independent of Y
∗
s .
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